17:33 EDT Biodesix affirms FY24 revenue view of $65M-$68M, consensus $66.2M Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on BDSX: Amgen upgraded, Peloton downgraded: Wall Street’s top analyst calls Biodesix initiated with a Buy at Lake Street Biodesix files to sell 30.43M shares of common stock for holders Biodesix 17.4M share Secondary priced at $1.15 Biodesix 17.4M share Spot Secondary priced at $1.15 Disclaimer & DisclosureReport an Issue
